REVA MEDICAL, INC (RVA)

Development of medical devices, specifically bioresorbable stent products.

On this page you will find:

Delayed share price Company announcements Price history chart Exchange Traded Options

Company details Closing prices Dividends Warrants & Structured Products ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code	Last	% Chg	Bid	Offer	Open	High	Low	Vol
RVA	0.575	0%	0.545	0.585	0.000	0.000	0.000	0

REVA MEDICAL, INC details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code	RVA
Securities	ASX Code, Security Description ------------------------------ RVA, Chess Depositary Interests 10:1
Official Listing Date	23 December, 2010
GICS Industry Group	Health Care Equipment & Services
Exempt Foreign?	No
Internet Address	http://www.revamedical.com
Registered Office Address	C/- Inteq Limited, Level 6, 175 Macquarie Street, SYDNEY, NSW, AUSTRALIA, 2000
Head Office Telephone	(858) 966-3000
Head Office Fax	(858) 966-3099
Share Registry	COMPUTERSHARE INVESTOR SERVICES PTY LIMITED LEVEL 4, 60 CARRINGTON STREET, SYDNEY, NSW, AUSTRALIA, 2000
Share Registry Telephone	1300 787 272

Directors / Senior Management
Mr Robert B. Stockman (Chairman, CEO) Mr Brian Dovey (Director) Ms Anne Keating (Director) Mr Gordon E. Nye (Director) Mr James J. Schiro (Director) Mr Robert Thomas (Director) Ms Katrina Thompson (CFO)

Company Secretary	Ms Katrina Thompson
Principal Activities	Development of medical devices, specifically bioresorbable stent products.

REVA MEDICAL, INC announcements

How are company announcements published on www.asx.com.au?

Date	Price sens.	Headline	Pages	PDF
21/05/2013		12-month Data from RESTORE Trial at EuroPCR	4	PDF
16/05/2013		AGM Dial-In Details	1	PDF
14/05/2013		Appointment of Managing Director International	2	PDF
09/05/2013		Quarterly Report on Form 10-Q	26	PDF
30/04/2013		Appendix 4C - quarterly	7	PDF
19/04/2013		Proxy Statement for 2013 AGM	59	PDF
28/03/2013		ReZolve2 Clinical Trial Initiation	2	PDF
01/03/2013		Form S-8 Filed with SEC	10	PDF
28/02/2013		Notice of Briefing Call & Cowen HC Conference Presentation	2	PDF
28/02/2013		Preliminary Final Report	109	PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date	Last	% Change	High	Low	Vol *
23 May 2013	0.575	-4.17%	0.590	0.575	63,045
22 May 2013	0.600	3.45%	0.600	0.580	410,000
21 May 2013	0.580	0%	0.580	0.560	221,685
20 May 2013	0.580	0%	0.580	0.580	179,442
17 May 2013	0.580	3.57%	0.580	0.540	88,451

* Volume of shares shown represents only those shares traded on ASX.

REVA MEDICAL, INC price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security RVA. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security RVA

Warrants & Structured Products

No warrants & Structured Products are available over the security RVA

ASX CFDs

No Contracts For Differences are available over the security RVA

MyASX: Login | Sign up